5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.04▲ | 2.04▲ | 2.03▲ | 2.22▼ | 2.68▼ |
MA10 | 2.03▲ | 2.03▲ | 2.03▲ | 2.52▼ | 3.16▼ |
MA20 | 2.04▲ | 2.04▲ | 2.05▼ | 2.69▼ | 3.92▼ |
MA50 | 2.03▲ | 2.11▼ | 2.37▼ | 3.31▼ | 5.10▼ |
MA100 | 2.04▲ | 2.42▼ | 2.58▼ | 3.96▼ | 8.41▼ |
MA200 | 2.12▼ | 2.60▼ | 2.85▼ | 4.78▼ | 10.49▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.010▲ | 0.021▲ | -0.050▼ | -0.104▼ |
RSI | 56.262▲ | 46.905▼ | 39.484▼ | 23.661▼ | 25.166▼ |
STOCH | 50.278 | 50.332 | 14.802▼ | 21.213 | 6.781▼ |
WILL %R | -33.333 | -68.182 | -73.077 | -92.857▼ | -97.802▼ |
CCI | 89.655 | 46.793 | -18.973 | -134.323▼ | -127.330▼ |
Thursday, September 11, 2025 05:36 AM
Lake Street analyst Ben Klieve lowered the firm’s price target on Bioceres (BIOX) to $5 from $8 and keeps a Buy rating on the shares. Q4 results were materially below all estimates in each segment, ...
|
Wednesday, September 10, 2025 10:20 AM
Bioceres Crop Solutions faces major losses, debt risks, and management issues. Click to learn key insights for speculative investors interested in BIOX stock.
|
Wednesday, September 10, 2025 10:08 AM
Despite a challenging quarter with revenue declines, Bioceres Crop Solutions Corp (BIOX) focuses on cost control and international growth to drive future profitability.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
12/09/25 | 2.07 | 2.085 | 2.01 | 2.04 | 604,428 |
11/09/25 | 2.09 | 2.145 | 2.01 | 2.09 | 588,863 |
10/09/25 | 2.25 | 2.295 | 2.01 | 2.06 | 942,672 |
09/09/25 | 2.33 | 2.4599 | 1.97 | 2.24 | 2,057,558 |
08/09/25 | 2.68 | 2.85 | 2.43 | 2.67 | 1,305,617 |
05/09/25 | 2.88 | 2.9386 | 2.71 | 2.71 | 284,293 |
04/09/25 | 2.82 | 2.87 | 2.80 | 2.85 | 256,269 |
03/09/25 | 2.91 | 2.95 | 2.81 | 2.815 | 312,436 |
02/09/25 | 2.75 | 2.91 | 2.68 | 2.89 | 782,485 |
29/08/25 | 2.88 | 2.88 | 2.71 | 2.79 | 293,942 |
|
|
||||
|
|
||||
|
|